MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) today announced six important new clinical trial results pertaining to the 4Kscore® test presented at the 2015 American Urological Association (AUA) annual meeting, May 15 to May 19, 2015, in New Orleans.
Date and time, title and location of the 4Kscore presentations at the New Orleans Morial Convention Center (NOMCC):
Friday, May 15, 1:00 pm – Moderated poster MP6-04: The 4Kscore Test predicts high-grade prostate cancer on biopsy with PSA less than 4 ng/mL; NOMCC #220-221
Help employers find you! Check out all the jobs and post your resume.
